BiotechDispatch

AusBiotech Invest puts capital and life sciences companies in the room

Investors and Australian life sciences company leaders met on the Gold Coast this week for AusBiotech Invest, a curated forum ...
BiotechDispatch

Quarterly update shows Telix holds course for a US$1 billion milestone year

Telix Pharmaceuticals has reaffirmed that it will pass US$1 billion in revenue and other income this year. Its third-quarter ...
BiotechDispatch

CSL appoints experienced global executive as new chief executive

CSL has named Deborah Waterhouse, a British pharmaceutical executive who previously led GSK in Australia, as its next chief ...
BiotechDispatch

Gold Coast hosts Australia's Biggest Week in Biotech as AusBiotech turns 40

Australia's life sciences sector has converged on the Gold Coast for what organiser AusBiotech describes as the event's ...
BiotechDispatch

BioNTech opens mRNA plant, putting Melbourne's north on the biotech map

BioNTech has opened its clinical-scale mRNA manufacturing and research facility at La Trobe University's Bundoora campus, ...
BiotechDispatch

AusBiotech Invest brings investors together around the capital needs of Australian life sciences

Today, AusBiotech Invest brings together investors and selected life sciences company leaders on the Gold Coast for a focused ...
BiotechDispatch

Philadelphia cyclotron to give Telix a dedicated source of rare alpha isotope

Telix has partnered with a new Franco-Belgian venture to produce astatine-211 in the United States. The isotope is scarce but ...
BiotechDispatch

Invion moves skin cancer light therapy to Phase 2 after early safety data

Invion has closed recruitment for its first-in-human trial of a light-activated treatment for non-melanoma skin cancer. The ...
BiotechDispatch

Island Pharmaceuticals moves towards Marburg candidate towards critical test

Island Pharmaceuticals will begin testing its antiviral Galidesivir against Marburg virus at a US Army laboratory this ...
BiotechDispatch

Algorae signs two-part deal with Umedica to expand Australian portfolio

Algorae Pharmaceuticals has signed two agreements with Mumbai-based manufacturer Umedica Laboratories. Together, they give the company's commercial arm access to a range of generic medicines for the ...